Acute viral myocarditis: Role of immunosuppression: A prospective randomised study

Cardiology in the Young

Volumn 20, Issue 5, 2010, Pages 509-515

  Aziz, Kalim U ^a   Patel, Najma ^a   Sadullah, Tareen ^a   Tasneem, Habiba ^a   Thawerani, Hasina ^a   Talpur, Saeed ^a  

^a NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES   (Pakistan)

Author keywords

Acute myocarditis; autoimmune driven myocarditis; clinical outcome of myocarditis; immune suppression in myocarditis; myocarditis and left ventricular failure; persistent myocarditis; randomised study in acute myocarditis; viral myocarditis

Indexed keywords

PREDNISOLONE;

ACUTE DISEASE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VIRUS MYOCARDITIS;

ACUTE DISEASE; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSION; MYOCARDITIS; PREDNISOLONE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 78649957572     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951110000594     Document Type: Article

References (34)

1. Aziz KU. Acute myocarditis in children, incidence, treatment and prognosis. A developing world problem. Pak Paed Cardiolo J 2001; 3: 121-126.
2. Younas M, Rathore AW, Sadiq M. Acute myocarditis - the commonest cause of cardiac failure in children. Pak Paed J 2003; 27: 63-67.
3. Chan KY, Iwahara M, Benson LN, Wilson GJ, Freedom RM. Immune suppressive therapy in the management of acute myocarditis in children:a clinical trial. J Am COll Cardiol 1991; 17: 458-460.
4. Why HJF, Meany BT, Richardson PJ, et al. Clinical and Prognostic significance of detection of Entero virus RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1999; 89: 2582-2589.
5. Lee K, McCrindle B, Bohn D, et al. Clinical outcome of acute myocarditis in children. Heart 1999; 82: 226-233.
6. English RF, Janosky JE, Ettedgui JA, Webber SA. Outcome of children with acute myocarditis. Cardiol Young 2004; 14: 448-493.
7. Nugent AW, Daubeny PEF, Chondros P, et al. Epidemiology of childhood cardiomyopathy in Australia. New Engl J Med 2003; 348: 1639-1646.
8. Burch M. Immunosuppressive treatment in pediatric myocarditis Scanty Evidence. Heart 2000; 90: 1103-1104.
9. McCarthy RE, Boehmer JP, Hruban RH, et al. Long term outcome of Fulminant as compared to acute (non fulminant) Myocarditis. New Engl J Med 2000; 342: 690-695.
10. Spotnitz MD, Lesch M. Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis Historical analysis, review of the literature and postulated unifying hypothesis. Prog Cardiovasc Diseases 2006; 49: 42-57.
11. Schultheiss HP, Kuhl U. Over view on chronic viral cardiomyopathy. Earnest Shering Res FoundWorkshop 2006; 55: 3-18.
12. Ciszewski A, Bilinska ZT, Lubiszewska B, et al. Dilated cardiomyopathy in children clinical course and prognosis. Pediatr cardiol 1994; 15: 121-126.
13. Balaji S, Wiles HB, Sens MA, Gillette PC. Immunosuppressive treatment for myocarditis in children with ventricular ectopic rhythm. Br Heart J 1994; 72: 354-359.
14. Ino T, Okubo M, Akimoto K, Nishimoto K, Yabutak Kawais S, Okada R. Corticosteroid therapy for ventricular tachycardia in children with silent lymphocytic myocarditis. J Pedtiatr 1995; 126: 304-308.
15. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001; 104: 1076-1082.
16. Kawai C. From myocarditis to Cardiomyopathy. Mechanism of inflammation and cell death. Circulation 1999; 99: 1091-1100.
17. Feldman AM, McNamara D. Myocarditis. New Engl J Med 2000; 343: 1388-1398.
18. Mason JW, Billingham ME, Ricci DR, et al. Treatment of acute inflammatory myocarditis associated by endomyocardial biopsy. Am J Cardiol 1980; 45: 1037-1044.
19. Martin AB, Webber S, Fricker FY, et al. Acute myocarditis rapid diagnosis by PCR in children. Circulation 1994; 90: 330-339.
20. Grogan M, Redfield MM, Baily KR, et al. Long term outcome of patients with biopsy proven myocarditis: Comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995; 26: 80-84.
21. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immunoglobulin in recent onset dilated cardiomyopathy. Circulation 2001; 103: 2254-2259.
22. Lauer B, Niederau C, Kuh U, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997; 30: 1354-1359.
23. Fuse K, Kodoma M, Okura Y, et al. Predictors of disease course in patients with acute myocarditis. Circulation 2000; 102: 2829-2835.
24. Hia CPP, Yip BCL, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis; an 18 year systematic review. Arc Dis Child 2004; 89: 580-584.
25. Ducker NA, Colan SD, Lewis AB, et al. Gammaglobulin treatment of acute myocarditis in pediatric population. Circulation 1994; 89: 252-257.
26. Takada H, Kishimoto C, Hiraoka Y. Therapy with immunoglobulins suppresses myocarditis in a Murine Coxsakie virus B3 model. Circulation 1995; 92: 1604-11611.
27. Jones SR, Herskowitz A, Aulchins GM, et al. Effect of immunosuppressive therapy in biopsy proved myocarditis and borderline myocarditis on ventricular function. AM J Cardiol 1991; 68: 370-376.
28. Maisch B, Hafnagel G, Schonian U, Hengstenberg C. The European study of Epidemiology and treatment of cardiac influmatory disease. Eur Heart J 1995; 16: 173-175.
29. Levi D, Alejo SJ. An approach to the treatment of pediatric myocarditis. Paedtr Drug 2002; 4: 637-647.
30. Gagliardi MG, Bevilacqua M, Bassono C, et al. Long term follow up of children and of children with dilated cardiomyopathy. Heart 2004; 90: 1167-1171.
31. Kuhl U, Pauschinger M, Schwimmbeck P, et al. Interferon beta treatment improves left ventricular function in patients with persistence of viral genome. Circulation 2003; 107: 2793-2798.
32. Ellis CR, Di Salvo T. Myocarditis: Basic and clinical aspects. Cardiol Rev 2007; 15: 170-177.
33. Matsumori A, Tomioka N, Kawai C. Protective effect of recombinant alpha interferon on Coxsackie B myocarditis in Mice. Am Heart J 1988; 115: 1229-1232.
34. Ahdoot J, Galindo A, Alijos JC, et al. Use of OKT3 for acute myocarditis in infants and children. J Heart Lung Transplant 2000; 19: 1118-1121.